We assessed the expression of MELK mRNA in malignant PC derived from MM patients and human myeloma cell lines (HMCL) and effects of the MELK inhibitor OTS167 on myeloma cells, including drug-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback